GlassScriptPhysician profile
Judith Archibold
NPI 1871877472
$3,478.18
in general payments reported to CMS, 2019-2025
18 companies · $1,085 in 2025
The $1,085 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.53 · 2020: $153 · 2021: $68.19 · 2022: $350 · 2023: $451 · 2024: $1,289 · 2025: $1,085.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,825.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $775.39 | 2023-2025 | Miebo, Vyzulta, Envista Envy Iol |
| Abbvie INC. | $478.75 | 2022-2025 | Lumigan, Ozurdex, Vuity |
| Tarsus Pharmaceuticals, INC. | $426.92 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $276.92 | 2019-2023 | |
| Alcon Vision LLC | $207.12 | 2021-2025 | Rocklatan, Tryptyr |
| Astellas Pharma US INC | $202.00 | 2024 | Izervay |
| Biotissue Holdings INC. | $185.05 | 2023-2025 | |
| Oyster Point Pharma, INC. | $176.66 | 2022-2024 | Tyrvaya, Ryzumvi |
| Amgen INC. | $141.84 | 2024-2025 | Tepezza |
| Apellis Pharmaceuticals, INC. | $108.80 | 2024 | Syfovre |
| Mallinckrodt Hospital Products INC. | $99.80 | 2024 | Acthar |
| Rxsight INC | $88.00 | 2022 | |
| Genentech USA, INC. | $77.94 | 2023-2024 | Vabysmo |
| Sun Pharmaceutical Industries INC. | $76.74 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $69.41 | 2019-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $43.96 | 2024 | Iyuzeh |
| Alimera Sciences, INC. | $26.19 | 2022 | |
| Allergan, INC. | $16.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Archibold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.